Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy

Amicus Therapeutics Current Ratio 2007-2018 | FOLD

Current and historical current ratio for Amicus Therapeutics (FOLD) from 2007 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Amicus Therapeutics current ratio for the three months ending June 30, 2018 was 10.88.
Amicus Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-06-30 $0.58B $0.05B 10.88
2018-03-31 $0.59B $0.14B 4.21
2017-12-31 $0.39B $0.07B 5.60
2017-09-30 $0.43B $0.07B 6.32
2017-06-30 $0.24B $0.10B 2.39
2017-03-31 $0.30B $0.11B 2.70
2016-12-31 $0.34B $0.11B 3.07
2016-09-30 $0.22B $0.09B 2.59
2016-06-30 $0.22B $0.08B 2.71
2016-03-31 $0.17B $0.06B 2.62
2015-12-31 $0.22B $0.07B 2.94
2015-09-30 $0.24B $0.04B 6.69
2015-06-30 $0.37B $0.02B 21.60
2015-03-31 $0.15B $0.02B 7.20
2014-12-31 $0.16B $0.02B 7.66
2014-09-30 $0.09B $0.01B 6.31
2014-06-30 $0.08B $0.01B 7.11
2014-03-31 $0.07B $0.01B 7.84
2013-12-31 $0.09B $0.01B 8.44
2013-09-30 $0.06B $0.01B 7.48
2013-06-30 $0.08B $0.01B 7.74
2013-03-31 $0.09B $0.01B 10.98
2012-12-31 $0.11B $0.01B 11.32
2012-09-30 $0.11B $0.01B 11.33
2012-06-30 $0.11B $0.02B 5.93
2012-03-31 $0.12B $0.02B 6.49
2011-12-31 $0.07B $0.02B 3.46
2011-09-30 $0.08B $0.02B 4.10
2011-06-30 $0.09B $0.02B 5.22
2011-03-31 $0.10B $0.02B 6.01
2010-12-31 $0.11B $0.02B 6.76
2010-09-30 $0.06B $0.01B 7.42
2010-06-30 $0.07B $0.01B 9.96
2010-03-31 $0.08B $0.01B 9.50
2009-12-31 $0.08B $0.01B 7.19
2009-09-30 $0.09B $0.02B 5.48
2009-06-30 $0.10B $0.02B 6.77
2009-03-31 $0.11B $0.01B 8.84
2008-12-31 $0.12B $0.01B 9.24
2008-09-30 $0.14B $0.02B 9.26
2008-06-30 $0.15B $0.02B 9.58
2008-03-31 $0.16B $0.02B 10.51
2007-12-31 $0.16B $0.02B 10.32
2007-09-30 $0.12B $0.01B 12.61
2007-06-30 $0.13B $0.01B 18.26
2007-03-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.417B $0.037B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.969B 15.03
Gilead Sciences (GILD) United States $98.924B 10.98
Biogen (BIIB) United States $68.211B 14.46
Celgene (CELG) United States $59.279B 11.84
Illumina (ILMN) United States $48.007B 60.14
Vertex Pharmaceuticals (VRTX) United States $47.394B 107.82
Regeneron Pharmaceuticals (REGN) United States $43.062B 24.21
Alexion Pharmaceuticals (ALXN) United States $28.459B 21.39
BioMarin Pharmaceutical (BMRN) United States $18.826B 0.00
Incyte (INCY) United States $13.798B 463.64
Seattle Genetics (SGEN) United States $11.870B 0.00
Sarepta Therapeutics (SRPT) United States $9.208B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.346B 0.00
Exact Sciences (EXAS) United States $8.279B 0.00
QIAGEN (QGEN) Netherlands $8.018B 26.22
Bluebird Bio (BLUE) United States $7.068B 0.00
Bio-Techne Corp (TECH) United States $7.000B 46.82
BeiGene (BGNE) Cayman Islands $6.811B 0.00
Alkermes (ALKS) Ireland $6.573B 0.00
Amarin (AMRN) Ireland $5.881B 0.00
Galapagos (GLPG) Belgium $5.281B 0.00
Exelixis (EXEL) United States $5.043B 16.43
Ligand Pharmaceuticals (LGND) United States $4.450B 39.42
Immunomedics (IMMU) United States $3.989B 0.00
Myriad Genetics (MYGN) United States $3.383B 35.94
Ultragenyx Pharmaceutical (RARE) United States $3.320B 0.00
Array BioPharma (ARRY) United States $3.279B 0.00
Horizon Pharma Public (HZNP) Ireland $3.203B 18.13
Intercept Pharmaceuticals (ICPT) United States $3.182B 0.00
Emergent Biosolutions (EBS) United States $3.176B 25.30
Blueprint Medicines (BPMC) United States $3.163B 0.00
GUARDANT HEALTH (GH) United States $3.152B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.068B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.865B 0.00
Ascendis Pharma (ASND) Denmark $2.664B 0.00
Halozyme Therapeutics (HALO) United States $2.605B 34.71
ARGENX SE-ADR (ARGX) Netherlands $2.519B 0.00
Repligen (RGEN) United States $2.479B 83.22
China Biologic Products (CBPO) China $2.459B 16.91
Genomic Health (GHDX) United States $2.423B 135.16
Acceleron Pharma (XLRN) United States $2.385B 0.00
MyoKardia (MYOK) United States $2.284B 0.00
Akcea Therapeutics (AKCA) United States $2.129B 0.00
Medicines (MDCO) United States $2.073B 0.00
Arena Pharmaceuticals (ARNA) United States $2.049B 0.00
REGENXBIO (RGNX) United States $2.009B 31.57
Cambrex (CBM) United States $1.995B 16.00
AnaptysBio (ANAB) United States $1.953B 0.00
Spark Therapeutics (ONCE) United States $1.908B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.888B 0.00
Reata Pharmaceuticals (RETA) United States $1.887B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.869B 0.00
Global Blood Therapeutics (GBT) United States $1.845B 0.00
Atara Biotherapeutics (ATRA) United States $1.739B 0.00
Denali Therapeutics (DNLI) United States $1.697B 0.00
Aimmune Therapeutics (AIMT) United States $1.654B 0.00
Clovis Oncology (CLVS) United States $1.607B 0.00
Puma Biotechnology (PBYI) United States $1.607B 0.00
Allakos (ALLK) United States $1.575B 0.00
Innoviva (INVA) United States $1.568B 10.06
Myovant Sciences (MYOV) United Kingdom $1.542B 0.00
G1 THERAPEUTICS (GTHX) United States $1.529B 0.00
Sangamo Therapeutics (SGMO) United States $1.504B 0.00
Rubius Therapeutics (RUBY) United States $1.467B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.440B 0.00
WAVE Life Sciences (WVE) Singapore $1.434B 0.00
Mirati Therapeutics (MRTX) United States $1.423B 0.00
Editas Medicine (EDIT) United States $1.385B 0.00
Insmed (INSM) United States $1.349B 0.00
Solid Biosciences (SLDB) United States $1.266B 0.00
IMMURON LTD (IMRN) Australia $1.186B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.174B 2242.00
Cellectis (CLLS) France $1.157B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.152B 0.00
NeoGenomics (NEO) United States $1.145B 200.29
Adaptimmune Therapeutics (ADAP) United Kingdom $1.119B 0.00
DBV Technologies (DBVT) France $1.100B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.098B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.083B 0.00
Intra-Cellular Therapies (ITCI) United States $1.073B 0.00
UniQure (QURE) Netherlands $1.073B 0.00
Lion Biotechnologies (IOVA) United States $1.071B 0.00
Intellia Therapeutics (NTLA) United States $1.064B 0.00
Retrophin (RTRX) United States $1.063B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.058B 0.00
Audentes Therapeutics (BOLD) United States $1.051B 0.00
Athenex (ATNX) United States $0.975B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.971B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.961B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.957B 0.00
Acorda Therapeutics (ACOR) United States $0.944B 19.69
Apellis Pharmaceuticals (APLS) United States $0.935B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.933B 0.00
Viking Therapeutics (VKTX) United States $0.926B 0.00
Revance Therapeutics (RVNC) United States $0.918B 0.00
Coherus BioSciences (CHRS) United States $0.907B 0.00
Aptinyx (APTX) United States $0.894B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.833B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.828B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.816B 0.00
InflaRx (IFRX) Germany $0.816B 0.00
Cara Therapeutics (CARA) United States $0.812B 0.00
Fate Therapeutics (FATE) United States $0.778B 0.00
Novavax (NVAX) United States $0.777B 0.00
CytomX Therapeutics (CTMX) United States $0.763B 0.00
Heska (HSKA) United States $0.745B 64.07
Epizyme (EPZM) United States $0.742B 0.00
Dynavax Technologies (DVAX) United States $0.723B 0.00
AVROBIO (AVRO) United States $0.697B 0.00
Mesoblast (MESO) Australia $0.695B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.694B 0.00
ANI Pharmaceuticals (ANIP) United States $0.666B 13.18
ObsEva SA (OBSV) Switzerland $0.629B 0.00
AC Immune SA (ACIU) Switzerland $0.626B 0.00
Anika Therapeutics (ANIK) United States $0.616B 25.90
Kura Oncology (KURA) United States $0.603B 0.00
UROGEN PHARMA (URGN) Israel $0.596B 0.00
MiMedx (MDXG) United States $0.590B 25.29
NuCana Sponsored ADR (NCNA) United Kingdom $0.587B 0.00
Principia Biopharma (PRNB) United States $0.562B 0.00
Arcus Biosciences (RCUS) United States $0.561B 0.00
Aduro Biotech (ADRO) United States $0.540B 0.00
Vericel (VCEL) United States $0.538B 0.00
UNITY Biotechnology (UBX) $0.534B 0.00
RA PHARMCTL INC (RARX) United States $0.525B 0.00
Prothena (PRTA) Ireland $0.520B 0.00
Inovio Pharmaceuticals (INO) United States $0.511B 0.00
Abeona Therapeutics (ABEO) United States $0.501B 0.00
ARVINAS INC (ARVN) United States $0.497B 0.00
Five Prime Therapeutics (FPRX) United States $0.495B 0.00
Stemline Therapeutics (STML) United States $0.493B 0.00
Senesco Technologies (ELOX) United States $0.488B 0.00
MediciNova (MNOV) United States $0.479B 0.00
Cytokineticsorporated (CYTK) United States $0.473B 0.00
Scholar Rock Holding (SRRK) United States $0.462B 0.00
Verastem (VSTM) United States $0.448B 0.00
Liquidia Technologies (LQDA) United States $0.445B 0.00
Kindred Biosciences (KIN) United States $0.443B 0.00
Zymeworks (ZYME) Canada $0.442B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.438B 0.00
Kezar Life Sciences (KZR) United States $0.434B 0.00
BeyondSpring (BYSI) United States $0.434B 0.00
Zealand Pharma (ZEAL) Denmark $0.432B 0.00
Sorrento Therapeutics (SRNE) United States $0.430B 73.60
UROVANT SCIENCS (UROV) United States $0.420B 0.00
Sinovac Biotech (SVA) China $0.415B 0.00
Replimune (REPL) United States $0.414B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.411B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.396B 0.00
PDL BioPharma (PDLI) United States $0.381B 5.35
MeiraGTx Holdings (MGTX) United States $0.380B 0.00
Merus (MRUS) Netherlands $0.371B 0.00
KODIAK SCIENCES (KOD) United States $0.365B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
GRITSTONE ONCLG (GRTS) United States $0.360B 0.00
Osiris Therapeutics (OSIR) United States $0.359B 0.00
ResTORbio (TORC) United States $0.349B 0.00
Eidos Therapeutics (EIDX) United States $0.345B 0.00
Albireo Pharma (ALBO) United States $0.340B 0.00
Geron (GERN) United States $0.338B 0.00
Kala Pharmaceuticals (KALA) United States $0.330B 0.00
Selecta Biosciences (SELB) United States $0.329B 0.00
SUTRO BIOPHARMA (STRO) United States $0.329B 0.00
Adverum Biotechnologies (ADVM) United States $0.327B 0.00
Kadmon Holdings (KDMN) United States $0.327B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.326B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.326B 0.00
Magenta Therapeutics (MGTA) United States $0.325B 0.00
Cellular Biomedicine (CBMG) United States $0.307B 0.00
Evelo Biosciences (EVLO) United States $0.306B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.306B 0.00
Athersys (ATHX) United States $0.298B 0.00
Axovant Sciences (AXON) United Kingdom $0.298B 0.00
Unum Therapeutics (UMRX) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
MannKind (MNKD) United States $0.294B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.292B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.283B 0.00
BioTime (BTX) United States $0.277B 0.00
NantKwest (NK) United States $0.276B 0.00
Celcuity (CELC) United States $0.274B 0.00
Seres Therapeutics (MCRB) United States $0.274B 0.00
Krystal Biotech (KRYS) United States $0.272B 0.00
Celyad SA (CYAD) Belgium $0.271B 0.00
TOCAGEN INC (TOCA) United States $0.268B 0.00
Synlogic (SYBX) United States $0.265B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.260B 0.00
Arbutus Biopharma (ABUS) Canada $0.258B 0.00
Syros Pharmaceuticals (SYRS) United States $0.256B 0.00
ADMA Biologics Inc (ADMA) United States $0.245B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.244B 0.00
Strongbridge Biopharma (SBBP) United States $0.239B 0.00
Kamada (KMDA) Israel $0.238B 18.50
Idera Pharmaceuticals (IDRA) United States $0.238B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.234B 0.00
Protagonist Therapeutics (PTGX) United States $0.230B 0.00
Agenus (AGEN) United States $0.224B 0.00
BioDelivery Sciences (BDSI) United States $0.223B 0.00
Allena Pharmaceuticals (ALNA) United States $0.222B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.221B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.214B 0.00
ChromaDex (CDXC) United States $0.207B 0.00
Mersana Therapeutics (MRSN) United States $0.197B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.193B 0.00
Palatin Technologies (PTN) United States $0.190B 7.83
Clearside Biomedical (CLSD) United States $0.187B 0.00
Cerecor (CERC) United States $0.186B 19.04
Compugen (CGEN) Israel $0.185B 0.00
Enzo Biochem (ENZ) United States $0.184B 0.00
Cohbar (CWBR) United States $0.180B 0.00
CorMedix Inc (CRMD) United States $0.180B 0.00
Constellation Pharmaceuticals (CNST) United States $0.177B 0.00
PSivida (EYPT) United States $0.172B 0.00
Intec Pharma (NTEC) Israel $0.166B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.164B 0.00
Signal Genetics (MGEN) United States $0.160B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.159B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.155B 0.00
Spero Therapeutics (SPRO) United States $0.155B 0.00
Cue Biopharma (CUE) United States $0.151B 0.00
Menlo Therapeutics (MNLO) United States $0.150B 0.00
OVID THERAPEUTC (OVID) United States $0.149B 0.00
Pfenex (PFNX) United States $0.144B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.141B 0.00
Mustang Bio (MBIO) United States $0.140B 0.00
VBI Vaccines (VBIV) United States $0.140B 0.00
Monster Digital (INNT) United States $0.138B 0.00
Eleven Biotherapeutics (SESN) United States $0.137B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
XOMA (XOMA) United States $0.135B 14.24
XBiotech (XBIT) United States $0.130B 0.00
Provention Bio (PRVB) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
Organovo Holdings (ONVO) United States $0.125B 0.00
Applied Genetic Technologies (AGTC) United States $0.123B 0.00
Motif Bio Plc (MTFB) United States $0.120B 0.00
ITUS (ANIX) United States $0.119B 0.00
Anavex Life Sciences (AVXL) United States $0.114B 0.00
Tapimmune (TPIV) United States $0.114B 0.00
Cidara Therapeutics (CDTX) United States $0.111B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.106B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Cel-Sci (CVM) United States $0.100B 0.00
Aptevo Therapeutics (APVO) United States $0.100B 0.00
VolitionRX (VNRX) Singapore $0.099B 0.00
VTv Therapeutics (VTVT) United States $0.098B 0.00
ScPharmaceuticals (SCPH) United States $0.098B 0.00
BioXcel Therapeutics (BTAI) United States $0.098B 0.00
Neothetics (EVFM) United States $0.098B 0.00
Leap Therapeutics (LPTX) United States $0.097B 0.00
Orgenesis (ORGS) United States $0.095B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.093B 0.00
Axsome Therapeutics (AXSM) United States $0.092B 0.00
Checkpoint Therapeutics (CKPT) United States $0.092B 0.00
Chiasma (CHMA) United States $0.090B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.088B 0.00
Protalix BioTherapeutics (PLX) Israel $0.087B 0.00
Aptose Biosciences (APTO) Canada $0.086B 0.00
Prima BioMed (IMMP) Australia $0.086B 0.00
NewLink Genetics (NLNK) United States $0.084B 0.00
Ophthotech (OPHT) United States $0.084B 0.54
OncoSec Medical (ONCS) United States $0.083B 0.00
Trevena (TRVN) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 0.00
Sophiris Bio (SPHS) United States $0.075B 0.00
Celldex Therapeutics (CLDX) United States $0.074B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.073B 0.00
Curis (CRIS) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.070B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Fortress Biotech (FBIO) United States $0.070B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.068B 0.00
BIONANO GENOMIC (BNGO) United States $0.068B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
Oncobiologics (ONS) United States $0.063B 0.00
Bellerophon Therapeutics (BLPH) United States $0.062B 0.00
Asterias Biotherapeutics (AST) United States $0.059B 0.00
VistaGen Therapeutics (VTGN) United States $0.058B 0.00
Oncolytics Biotech (ONCY) Canada $0.057B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.048B 0.00
Celsion (CLSN) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.047B 0.00
GTx (GTXI) United States $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
AZURRX BIOPHARM (AZRX) United States $0.042B 0.00
Aileron Therapeutics (ALRN) United States $0.041B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
Advaxis (ADXS) United States $0.038B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
BioPharmX (BPMX) United States $0.035B 0.00
Galena Biopharma (SLS) United States $0.033B 0.00
Proteon Therapeutics (PRTO) United States $0.031B 0.00
CytRx (CYTR) United States $0.028B 0.00
Vical (VICL) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
OvaScience (OVAS) United States $0.027B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Edge Therapeutics (EDGE) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.025B 51.33
Gemphire Therapeutics (GEMP) United States $0.024B 0.00
Arsanis (ASNS) United States $0.023B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Histogenics (HSGX) United States $0.020B 0.00
RestorGenex (DFFN) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Soligenix (SNGX) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 6.31
Adial Pharmaceuticals (ADIL) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
IBio (IBIO) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Neuralstem (CUR) United States $0.015B 0.00
Oragenics (OGEN) United States $0.013B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Cerulean Pharma (DARE) United States $0.013B 0.00
Flex Pharma (FLKS) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.007B 0.00
AmpliPhi Biosciences (APHB) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.002B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00